{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:40:07Z","timestamp":1780321207610,"version":"3.54.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The development of a safe and effective vaccine against<jats:italic>Yersinia pestis<\/jats:italic>, the causative organism for plague disease, remains an important global health priority. Studies have demonstrated effective immune-based protection against plague challenge that is induced by plague antigen subunit vaccination in an aqueous alhydrogel formulation; however, whether these candidate vaccines in this formulation and presentation, induce long-lasting immunological memory in the form of durable cellular and antibody recall responses has not been fully demonstrated. In this study, we analyzed germinal center T follicular helper and germinal center B cell responses following F1V and F1 + V plague subunit immunization of mice with vaccines formulated in various adjuvants. Our data demonstrate that recombinant plague protein immunization formulated with IL-2\/GM-CSF cytokines bound to alhydrogel adjuvant drive an increase in the magnitude of the germinal center T follicular helper and germinal center B cell responses following primary immunization, compared to vaccines formulated with Alhydrogel adjuvant alone. In contrast, plague protein subunit immunization combined with CpG ODN bound to alhydrogel increased the magnitude and duration of the germinal center Tfh and B cell responses following booster immunization. Importantly, enhanced germinal center Tfh and B cell responses correlated with long-lasting and high F1V-specific antibody titers and more robust antibody recall responses to F1V re-exposure. These findings indicate that vaccine formulations that drive enhancement of the germinal center Tfh and B cell responses are critical for inducing durable plague-specific humoral immunity.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1017385","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T06:28:31Z","timestamp":1666938511000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["The magnitude of the germinal center B cell and T follicular helper cell response predicts long-lasting antibody titers to plague vaccination"],"prefix":"10.3389","volume":"13","author":[{"given":"Darrell R.","family":"Galloway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen X.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Houston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gage","family":"Gregersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Diane","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank W.","family":"Falkenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"Herron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Scott","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.09.070","article-title":"A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin\/F1\/V, in healthy adult volunteers (DMID 08-0066)","volume":"35","author":"Frey","year":"2017","journal-title":"Vaccine"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.07.103","article-title":"Robust Th1 cellular and humoral responses generated by the yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague","volume":"37","author":"Bowen","year":"2019","journal-title":"Vaccine"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/jat.3550","article-title":"A safety and immunogenicity study of a novel subunit plague vaccine in cynomolgus macaques","volume":"38","author":"Liu","year":"2018","journal-title":"J Appl Toxicol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10020145","article-title":"Predictors of survival after vaccination in a pneumonic plague model","volume":"10","author":"Moore","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5696542","DOI":"10.1155\/2017\/5696542","article-title":"Plague: A millenary infectious disease reemerging in the XXI century","volume":"2017","author":"Gracio","year":"2017","journal-title":"BioMed Res Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-011-3380-6","article-title":"Progress on plague vaccine development","volume":"91","author":"Rosenzweig","year":"2011","journal-title":"Appl Microbiol Biotechnol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-369408-9.00054-8","article-title":"Plague","volume":"27","author":"Williamson","year":"2009","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-024-0890-4_12","article-title":"Plague vaccines: Status and future","volume":"918","author":"Sun","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41541-019-0105-9","article-title":"Plague vaccine: recent progress and prospects","volume":"4","author":"Sun","year":"2019","journal-title":"NPJ Vaccines"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.08.031","article-title":"Molecular history of plague","volume":"22","author":"Drancourt","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.epidem.2018.05.001","article-title":"The 2017 plague outbreak in Madagascar: Data descriptions and epidemic modelling","volume":"25","author":"Nguyen","year":"2018","journal-title":"Epidemics"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management. working group on civilian biodefense","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2005.11928049","article-title":"Plague: from natural disease to bioterrorism","volume":"18","author":"Riedel","year":"2005","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2013etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5273.367","article-title":"Role of the yersinia pestis hemin storage (hms) locus in the transmission of plague by fleas","volume":"273","author":"Hinnebusch","year":"1996","journal-title":"Science"},{"key":"B17","year":"2018"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00602","article-title":"Plague vaccine development: Current research and future trends","volume":"7","author":"Verma","year":"2016","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1038\/emi.2012.34","article-title":"Plague vaccines: current developments and future perspectives","volume":"1","author":"Feodorova","year":"2012","journal-title":"Emerg Microbes Infect"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-021-11389-6","article-title":"Plague vaccines: New developments in an ongoing search","volume":"105","author":"Rosenzweig","year":"2021","journal-title":"Appl Microbiol Biotechnol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41435-019-0065-0","article-title":"Yersinia pestis and plague: An updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics","volume":"20","author":"Demeure","year":"2019","journal-title":"Genes Immun"},{"key":"B22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.micpath.2006.09.003","article-title":"Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates","volume":"42","author":"Williamson","year":"2007","journal-title":"Microb Pathog"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.04.084","article-title":"Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague","volume":"29","author":"Williamson","year":"2011","journal-title":"Vaccine"},{"key":"B24","article-title":"Studies on immunization against plague. i. the isolation and characterization of the soluble antigen of pasteurella pestis","volume":"68","author":"Baker","year":"1952","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.21236\/AD0299868","article-title":"Biosynthesis and purification of V and W antigen in pasteurella pestis","volume":"91","author":"Lawton","year":"1963","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.84.5.475","article-title":"Studies on the antigens of pasteurella pestis and pasteurella pseudotuberculosis","volume":"84","author":"Lawton","year":"1960","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00597-12","article-title":"Evaluation of protective potential of yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine","volume":"20","author":"Erova","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.726416","article-title":"Impact of toll-like receptor-specific agonists on the host immune response to the yersinia pestis plague rF1V vaccine","volume":"12","author":"Biryukov","year":"2021","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1600-065X.2012.01124.x","article-title":"Germinal center selection and the development of memory b and plasma cells","volume":"247","author":"Shlomchik","year":"2012","journal-title":"Immunol Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/science.1175870","article-title":"Bcl6 and blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation","volume":"325","author":"Johnston","year":"2009","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/science.1176676","article-title":"Bcl6 mediates the development of T follicular helper cells","volume":"325","author":"Nurieva","year":"2009","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.07.002","article-title":"The transcriptional repressor bcl-6 directs T follicular helper cell lineage commitment","volume":"31","author":"Yu","year":"2009","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.94","article-title":"T Follicular helper cells in space-time","volume":"16","author":"Qi","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4049\/jimmunol.0903505","article-title":"Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150)","volume":"185","author":"Yusuf","year":"2010","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.10.085","article-title":"Direct probing of germinal center responses reveals immunological features and bottlenecks for neutralizing antibody responses to HIV env trimer","volume":"17","author":"Havenar-Daughton","year":"2016","journal-title":"Cell Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.cell.2019.04.012","article-title":"Slow delivery immunization enhances HIV neutralizing antibody and germinal center responses via modulation of immunodominance","volume":"177","author":"Cirelli","year":"2019","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201254","article-title":"Modulating the quantity of HIV env-specific CD4 T cell help promotes rare b cell responses in germinal centers","volume":"218","author":"Lee","year":"2021","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.immuni.2020.11.009","article-title":"SARS-CoV-2 mRNA vaccines foster potent antigen-specific germinal center responses associated with neutralizing antibody generation","volume":"53","author":"Lederer","year":"2020","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14939","article-title":"Immunogenicity and safety of HBAI20 hepatitis b vaccine in non-responders: Double-blinded, randomised, controlled phase 2 trial","volume":"41","author":"Koc","year":"2021","journal-title":"Liver Int"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1021\/bp050098r","article-title":"Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague","volume":"21","author":"Powell","year":"2005","journal-title":"Biotechnol Prog"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.02.020","article-title":"Distinct memory CD4+ T cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection","volume":"38","author":"Hale","year":"2013","journal-title":"Immunity"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600318","article-title":"A cytokine-independent approach to identify antigen-specific human germinal center T follicular helper cells and rare antigen-specific CD4+ T cells in blood","volume":"197","author":"Dan","year":"2016","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"994","DOI":"10.4049\/jimmunol.1600320","article-title":"Cytokine-independent detection of antigen-specific germinal center T follicular helper cells in immunized nonhuman primates using a live cell activation-induced marker technique","volume":"197","author":"Havenar-Daughton","year":"2016","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1486154","article-title":"One year immunogenicity and safety of subunit plague vaccine in Chinese healthy adults: An extended open-label study","volume":"14","author":"Hu","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"B46","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.chom.2012.09.008","article-title":"A blueprint for HIV vaccine discovery","volume":"12","author":"Burton","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T Follicular helper cell biology: A decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"B48","doi-asserted-by":"publisher","first-page":"88","DOI":"10.12688\/f1000research.7388.1","article-title":"Can follicular helper T cells be targeted to improve vaccine efficacy","volume":"5","author":"Linterman","year":"2016","journal-title":"F1000Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.06.039","article-title":"Dual route vaccination for plague with emergency use applications","volume":"36","author":"Moore","year":"2018","journal-title":"Vaccine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1017385\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T10:42:43Z","timestamp":1678444963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1017385\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2022.1017385"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1017385","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,28]]},"article-number":"1017385"}}